Baxter International, Inc. (BAX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Core Viewpoint - Investors in Baxter International, Inc. have the opportunity to lead a securities fraud class action lawsuit due to undisclosed systemic defects in the Novum LVP device that resulted in serious patient risks [2]. Summary by Sections Lawsuit Details - The lawsuit alleges that from February 23, 2022, to July 30, 2025, Baxter failed to disclose significant issues with the Novum LVP, including systemic defects leading to malfunctions such as underinfusion, overinfusion, and non-delivery of fluids, which posed risks of serious injury or death to patients [2]. - Baxter was reportedly aware of multiple device malfunctions, injuries, and deaths related to these defects but did not adequately address them, leading to misleading positive statements about the company's operations and prospects [2]. Participation Information - Investors who suffered losses related to Baxter are encouraged to participate in the ongoing lawsuit, with a lead plaintiff deadline set for December 15, 2025 [2]. - Interested parties can contact The Law Offices of Frank R. Cruz for more information or to participate in the class action [3][4].